The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure

European Journal of Heart Failure

Volumn 9, Issue 9, 2007, Pages 942-948

  Macchia, Alejandro ^a   Monte, Simona ^a   Romero, Marilena ^a   D'Ettorre, Antonio ^a   Tognoni, Gianni ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

Chronic heart failure; Chronic obstructive pulmonary disease; Medical record linkage

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRONCHODILATING AGENT; CARVEDILOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; SPIRONOLACTONE; STEROID; XANTHINE DERIVATIVE;

ACUTE HEART INFARCTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES;

EID: 34548262663     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.06.004     Document Type: Article

References (42)

1. de Giuli F., Khaw K.T., Cowie M.R., Sutton G.C., Ferrari R., and Poole-Wilson P.A. Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail 3 (2005) 295-302
2. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (1997) 1436-1442
3. Peruzza S., Sergi G., Vianello A., et al. Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Resp Med 97 (2003) 612-617
4. Lee W.C., Chavez Y.E., Baker T., and Luce B.R. Economic burden of heart failure: a summary of recent literature. Heart Lung 33 (2004) 362-371
5. Strassels S.A., Smith D.H., Sullivan S.D., and Mahajan P.S. The costs of treating COPD in the United States. Chest 119 (2001) 344-352
6. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349 (1997) 1498-1504
7. Curkendall S.M., DeLuise C., Jones J.K., et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 16 (2006) 63-70
8. Rutten F.H., Moons K.G., Cramer M.J., et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 331 (2005) 1379
9. Rutten F.H., Cramer M.J., Grobbee D.E., et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26 (2005) 1887-1894
10. Rutten F.H., Cramer M.J., Lammers J.W., Grobbee D.E., and Hoes A.W. Heart failure and chronic obstructive pulmonary disease: an ignored combination?. Eur J Heart Fail 8 (2006) 706-711
11. Donaldson G.C., Seemungal T.A., Patel I.S., et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128 (2005) 1995-2004
12. Sin D.D., and Man S.F. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?. Thorax 61 (2006) 1-3
13. Saetta M., Turato G., Maestrelli P., Mapp C.E., and Fabbri L.M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1304-1309
14. Eichhorn E.J. Prognosis determination in heart failure. Am J Med 110 7A (2001) 14S-36S
15. Brophy J.M., Dagenais G.R., McSherry F., Williford W., and Yusuf S. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 116 (2004) 300-304
16. Pocock S.J., Wang D., Pfeffer M.A., et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27 (2006) 65-75
17. Nieminen M.S., Brutsaert D., Dickstein K., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006) 2725-2736
18. Fletcher C., and Peto R. The natural history of chronic airflow obstruction. BMJ 1 (1997) 1645-1648
19. Schneeweiss S., and Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58 (2005) 323-337
20. Ayanian J.Z. Using administrative data to assess health care outcomes. Eur Heart J 20 (1999) 1689-1691
21. Lancet 366 (2005) 2005-2011
22. International classification of diseases, 9th revision (clinical modification) (1998), Public Health Service, US Department of Health and Human Services, Washington
23. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs (2003), WHO, Oslo, Norway
24. D'Ettorre A. ReClust. Technical Report 2005 (2006). http://easi.negrisud.it/software%20/reclust/index.html http://easi.negrisud.it/software /reclust/index.html (30 September)
25. CINECA. The Interuniversity Consortium of Northeastern Italy (2006). http://www.cineca.it/en/area/inf_syst_serv_health.htm Accessed at www.cineca.it/en/area/inf_syst_serv_health.htm (30 September)
26. Monte S., Macchia A., Pellegrini F., et al. Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J 27 (2006) 2217-2223
27. Lepore V., D'Ettorre A., Valerio M., et al. From pharmacoepidemiology to the epidemiology of delivered care. Ital J Clin Pharm 16 (2002) 102-107
28. Monte S., Fanizza C., Romero M., Rossi E., De Rosa M., and Tognoni G. Administrative databases as a basic tool for the epidemiology of cardiovascular diseases. G Ital Cardiol 3 (2006) 206-216
29. Scurti V., Font, Monte S., et al. Pharmacoepidemiology of chronic treatments. Definitions, methodology, model scenarios. Ital J Clin Pharm 19 (2005) 102-109
30. Joynt K.E., Whellan D.J., and O'connor C.M. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 10 (2004) 258-271
31. Kunik M.E., Roundy K., Veazey C., et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 127 (2005) 1205-1211
32. Lin D.Y., Psaty B.M., and Krommal R.A. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 54 (1998) 948-963
33. Halbert R.J., Isonaka S., George D., and Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease?. Chest 123 (2003) 1684-1692
34. Mannino D.M., Homa D.M., Akinbami L.J., Ford E.S., and Redd S.C. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir Care 47 (2002) 1148-1149
35. Connors Jr. A.F., Dawson N.V., Thomas C., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease: the SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154 (1996) 959-967
36. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., and Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
37. Egred M., Shaw S., Mohammad P., Waitt P., and Rodriguez E. Under-use of beta blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease. QJM 98 (2005) 493-497
38. Le Jemtel T.H., Padeletti M., and Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 49 (2007) 171-180
39. Kjoller E., Kober L., Iversen K., Torp-Pedersen C., and Trace Study Group. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail 6 (2004) 71-77
40. Sirak T.E., Jelic S., and Le Jemtel T.H. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 44 (2004) 497-502
41. Salpeter S.R., and Salpeter E.E. Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis. Chest 125 (2004) 2309-2321
42. Ingelsson E., Arnlov J., Sundstrom J., and Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7 (2005) 787-791